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An unusual presentation of Epstein-Barr Virus induced
hepatitis in a 15-month-old child
Apresentação incomum de hepatite induzida por Epstein-Barr Virus em criança
de 15 meses de idade
Gabriel B. Tofani1, Tadeu S. Ferreira², Gustavo P. Irffi1, Daniela C. S. M. do Valle³
ABSTRACT
Objective: We report an atypical case of hepatitis in an infant that could be helpful to physicians of
various specialties, as it demonstrates an atypical clinical and laboratorial manifestation of a disease not
so common at that age and that could have gone undiagnosed.
Case Description: A 15-month-old female, immunocompetent patient was referred to the hospital with
a 3-day history of fever, vomiting, and diarrhea. The patient presented with alternation between sleepi-
ness and irritation associated with rapid increase in serum liver enzymes levels, but no jaundice. Neuro-
logic evaluation showed no meningeal signs and no encephalic morphological abnormalities were ob-
served in a cranial CT scan. Treatment consisted of symptomatic medication and daily evaluation for
signs of hepatic encephalopa- thy or bleeding. A serological panel showed negative IgM but positive IgG
reactivity against Cytomega- lovirus (CMV) and IgM and IgG negative immunoreactivity against HAV.
She was not tested for Hepatits B (HBV) or Hepatits C (HCV). Positive immunoreactivity against the
Epstein-Barr virus capsid antigen (EBV VCA) IgM and negative reactivity against IgG, indicated a diag-
nosis of EBV-induced acute hepatitis. The patient was discharged asymptomatic after 11 days, with
decreasing serum liver enzymes levels. A 15-day follow up evidenced complete remission of symptoms
and normalized laboratory tests.
Comments: Hepatic involvement in infections by Epstein-Barr Virus is common, presenting with mod-
erate and transient increase in liver enzymes. It can go undetected and resolve spontaneously, while
clinical manifestations of hepatitis are infrequent. In this report, we present an unusual case of a pediatric
patient with hepatitis induced by EBV infection, along with a review of the literature. According to our
search, no other EBV-induced hepatitis case reports have been published involving an immunocompe-
tent patient under 2 years of age.
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Introduction
Viral hepatitis can be caused by several vi-
ruses, including the Epstein-Barr Virus (EBV).1,2 EBV
is a human herpesvirus (HHV-4) of approximately
120 to 180 nm in diameter, composed of a double-
stranded, linear DNA genome surrounded by a pro-
tein capsid.3 Its prevalence varies by geographic
location,3 but it is estimated that more than 90% of
the world population is infected.4
Infectious mononucleosis (IM) is the most
known acute clinical manifestation of EBV infection.5
It often begins with malaise and headache, followed
by the development of exudative tonsillitis and/or
pharyngitis, lymphadenopathy and moderate to high
fever.3, 5 Adolescents and young adults usually
present a very typical manifestation, while infection
before the age of 10 is commonly asymptomatic or
produces an acute illness that is often misdiagnosed.3
The majority of patients with IM recover with-
out complications. It is estimated that EBV infec-
tion has hepatic involvement in 10% of young adults
and 30% of the elderly, with varying severity.5, 6
Moderate and transitory increase in liver enzymes
is common and can go undetected and resolve spon-
taneously, while clinical manifestations of hepatitis
are infrequent. Jaundice is a rare manifestation,
occurring in about 5% of patients.5,7
Hepatitis associated with EBV infection in chil-
dren has been reported since the 1970s.8 However,
description of EBV-induced acute hepatitis in infants
is scant in the literature. We present a case of an
immunocompetent 15-month-old patient with EBV-
related hepatitis which showed atypical clinical mani-
festations and unusual laboratory findings.
Case report
A 15-month-old girl presented at the hospi-
tal, referred from an emergency care unit, with a 3-
day history of fever (38.2ºC), vomiting, and diar-
rhea. On admission, she was noted to be clinically
stable, with no signs of dehydration, cyanosis, or
jaundice. No alterations on oroscopy, otoscopy, car-
diac or respiratory systems were observed. No vis-
ceromegaly or lymphadenopathy was found. The
patient also showed sensory alterations, alternating
between irritation and sleepiness. She did not present
RESUMO
Objetivo: Este relato de uma hepatite em um paciente pediátrico pode trazer benefícios para médicos
de diversas especialidades, pois ele demonstra um quadro clínico e laboratorial atípicos de uma doença
não tão comum nessa faixa etária e que poderia não ter sido diagnosticada.
Descrição do Caso: Uma paciente, de 15 meses de idade, foi referenciada ao hospital com história de
3 dias de febre, vômitos e diarréia. A paciente apresentava alternância entre sonolência e irritação
associada com rápida elevação das enzimas hepáticas, mas sem icterícia. Ao exame neurológico não
foram evidenciados sinais meníngeos e a tomografia computadorizada de crânio não apresentou altera-
ções. O tratamento consistiu em medicação sintomática junto à avaliação diária dos sinais de encefalo-
patia hepática ou sangramentos. O painel sorológico foi de IgM negativo e IgG positivo para
Citomegalovirus (CMV) e IgM e IgG negativos para Anti-HAV. Em contraste, encontrou-se no soro IgM
Imunorreativa contra o antígeno do capsídeo do vírus Epstein-Barr (EBV VCA), o que confirmou um
diagnóstico de hepatite pelo EBV. A paciente recebeu alta hospitalar assintomática após 11 dias de
internação, com declínio dos valores séricos das transaminases. Um acompanhamento após 15 dias da
alta evidenciou completa remissão dos sintomas.
Comentários: O envolvimento do fígado com infecções pelo vírus Epstein-Barr é comum, apresentando
elevações moderadas e transitórias das enzimas hepáticas. Ela pode não ser detectada e ser autolimita-
da, enquanto manifestações hepáticas são infrequentes. Nesse relato de caso, é apresentado um qua-
dro pediátrico atípico de um paciente que desenvolveu hepatite induzido pela infecção por EBV, além de
uma revisão na literatura. De acordo com nossa busca, nenhum outro caso de hepatite induzida por EBV
foi publicado envolvendo um paciente imunocompetente com idade inferior a 2 anos.
Palavras-chave: Herpesvirus Humano 4. Criança. Hepatite.
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any meningeal signs. After a neurologic evaluation,
a cranial computed tomography was performed
which showed no morphological abnormalities.
Laboratory studies performed after the evalu-
ation upon admission yielded hemoglobin: 13.8g/
dL, hematocrit 43.7%, medium corpuscular volume
79.8fL, medium corpuscular hemoglobin 25.3 g/dL.
The white blood count was 10800 cells with 37%
neutrophils, 3% band neutrophils and 53% lympho-
cytes (2% atypical lymphocytes). Platelet count was
304000 units. The serum levels for potassium, so-
dium, glucose, C reactive protein, urea, creatinine
and venous blood gasometry were within normal
range. Serum aspartate transaminase (AST) level
was 522 U/L (normal range, 14-36 U/L), and ala-
nine transaminase (ALT) was 262 U/L (normal range,
9-52 U/L). The time course of intracellular liver en-
zymes is shown in Figure1. International Normal-
ized Ratio (INR) was 2.26, prothrombin activity was
34% and the activated partial thromboplastin time
(APTT) was 47.1 seconds (control 33.4s).
Her serum tested negative for IgG [indirect
chemiluminescence assay using monoclonal
antibodiesa] and positive for IgM against Epstein-
Barr virus viral capsid antigen (EBV VCA) [indirect
chemiluminescence assay using monoclonal
antibodiesb]. Cytomegalovirus (CMV) serologic ex-
aminations were IgG positive [eletrochemilumines-
cence, µ-capture assayc] and IgM negative [eletro-
chemiluminescence, one-step double antigen sand-
wich assayd]. Anti-HAV tests were negative for both
IgM and IgG [eletrochemiluminescence assay using
monoclonal antibodiese]. The serum was not tested
for Hepatits B (HBV) or Hepatits C (HCV).
After the second day, she had no fever, but
still presented sporadic vomiting and elevated liver
enzymes. She presented with alternation between
sleepiness and irritation and was daily evaluated
for signs of hepatic encephalopathy or bleeding. For
this reason, she was kept in observation even with
the remission of other symptoms. On day four, de-
spite the peak in serum liver enzymes levels, the
patient had only one episode of vomiting and still
alternated between sleepiness and irritation, which
only disappeared after day eight of hospital stay.
Her treatment regimen consisted of only symptom-
atic medication. Administration of vitamin K was not
performed due to a progressive decrease of INR.
On day 11 after admission, the patient was dis-
charged from the hospital without symptoms, and
the parents were advised to return to the hospital
in case of adverse events. She returned for a fol-
low-up appointment 15 days after discharge, as-
ymptomatic and with a normal physical examina-
Figure 1: Time course of serum AST and ALT activities during the 11 days period
c Roche Diagnostics Ltda. Elecsys® CMV IgG Assay.
d Roche Diagnostics Ltda. Elecsys® CMV IgM Assay.
e Roche Diagnostics Ltda. Elecsys® Anti-HAV Assay.
a DiaSorin LIAISON® EBV IgG Assay.
b DiaSorin LIAISON® EBV IgM Assay.
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tion. Liver function tests and complete blood count
were normal, but the patient had not done the con-
firmatory serological tests that were asked.
Discussion
An electronic search was performed in order
to compare this case with others that had already
been published about pediatric patients, Articles on
EBV hepatitis were identified in the PubMed data-
base using the terms “EBV” or “Epstein” and “hepa-
titis” on the title. No date-limit was stablished. Other
requirements were: case reports and human re-
search. Seventy seven papers were found and manu-
ally chosen by abstract analysis.
Limited and inconclusive data about hepatic
manifestations of EBV infection are available.7
Drebber et al. (2006) proposed that the diagnosis
of EBV hepatitis should be based on four param-
eters: elevated serum levels of AST and ALT, sero-
logical EBV activity, demonstration of viral genome
by polymerase chain reaction (PCR) or EBV-encoded
RNA in-situ hybridization (EBER-RISH) and histo-
pathological changes on liver tissue biopsy. How-
ever, these parameters are unreliable if not evalu-
ated together. In our case, a liver biopsy would not
benefit the patient, and PCR testing for viral ge-
nome was not performed.
The symptoms of acute hepatitis are usually
milder and shorter in duration in children when com-
pared to adults.9 They are clinically indistinguish-
able between the viruses and usually consist of
vague abdominal pain, vomiting, fever and jaun-
dice.1,9 Kofteridis et al. (2011) demonstrated that
serum AST and ALT levels started to rise 2 days
after the onset of illness and showed peaks, but
values did not go higher than 10 times the upper
normal limit (360 U/L for AST and 520 U/L for ALT)
after 13 days. His study included 47 patients with
documented EBV infection, of median age of 18.5
years and average of 2.9 liver function tests per-
formed per patient. Our patient, however, presented
AST and ALT levels over 45 times the upper normal
limit in 4 days, indicating acute hepatocyte injury.
A retrospective study in Korea, 2014, evalu-
ated 36 patients diagnosed with primary EBV hepa-
titis based on the elevation of ALT levels over 45 U/
L, early positive EBV IgM (VCA) or early positive
EBV IgG (VCA) with positive EBV PCR. It showed
that the most common clinical feature was fever,
with mean duration of 9 days, followed by cervical
lymphadenopathy. The classical triad of IM was seen
in about 50% of the patients. Serum ALT levels over
10 times the upper normal limit were observed in
27% of the patients and was more common in those
with serum alkaline-phosphatase (ALP) and ã-
glutamyl transferase (GGT) also increased for their
age and gender. Serum ALT above 1000 U/L was
seen in four patients.10 Our patient presented with
fever for 4 days, but no signs of lymphadenopathy
or tonsillar exudates. She also did not present with
hepatomegaly nor splenomegaly. Her ALT levels
surpassed the 2000 U/L mark, but she had no in-
crease of either GGT or ALP. Only 8 out of the 36
patients were under 2 years old and these cases
were not reported in greater detail.
Andiman (1976) demonstrated the associa-
tion of primary infection, with atypical illness in three
children in whom he suspected a viral etiology, but
hepatitis was only seen in one of them, who was 5
years old. A 17-month-old infant had a nonspecific
febrile illness with upper respiratory infection. And
a 3-year-old patient presented with fever, hemolytic
anemia and adenopathy. According to our search,
no other EBV-induced hepatitis cases have been
published involving an immunocompetent patient
under 2 years of age.
Our patient presented with a lack of the usual
clinical manifestations of EBV infection and an un-
expected trend in LFTs. Her age and neurological
manifestations, which justified a prolonged hospi-
tal course, and a lack of other similar reports makes
this case unique.
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